Mark Kiel

Company: Genomenon Inc.

Job title: Chief Science Officer & Founder

Seminars:

Inside the Genomics of ALS – Implications for Drug Discovery & Development 9:00 am

Discover how the genetic heterogeneity of ALS has ramifications for clinical practice Understand the elements of comprehensive genomic landscapes and why they are needed to fully understand the genetic basis of ALS Review the ALS Genomic Landscape, and learn how to identify key findings and their implications for ALS drug discovery developmentRead more

day: Day Two AM